Sutro Biopharma to Participate in Two Virtual Investor Conferences in June

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., June 15, 2021 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced that Chief Executive Officer,...

Click to view original post